We are live on ! Find out more
EC

Eleva Capital Portfolio holdings

AUM $343M
This Fund
S&P 500
This Quarter Est. Return
-14.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$343M
AUM Growth
Cap. Flow
+$382M
Cap. Flow %
111.1%
Top 10 Hldgs %
97.63%
Holding
24
New
24
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$312M
2
AS icon
Amer Sports
AS
+$10.9M
3
NVDA icon
NVIDIA
NVDA
+$9.54M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.79M
5
NFLX icon
Netflix
NFLX
+$7.68M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Materials 81.31%
2 Technology 6.21%
3 Communication Services 6.04%
4 Consumer Discretionary 4.34%
5 Healthcare 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRH icon
1
CRH
CRH
$63B
$279M 81.27%
+2,654,974
New +$312M
AS icon
2
Amer Sports
AS
$19.8B
$9.84M 2.86%
+298,802
New +$10.9M
NVDA icon
3
NVIDIA
NVDA
$5.25T
$9.07M 2.64%
+52,002
New +$9.54M
NFLX icon
4
Netflix
NFLX
$334B
$8.38M 2.44%
+87,190
New +$7.68M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.17T
$8.04M 2.34%
+27,967
New +$8.79M
TSM icon
6
TSMC
TSM
$2.16T
$6.51M 1.89%
+21,411
New +$7.37M
ANET icon
7
Arista Networks
ANET
$232B
$5.77M 1.68%
+46,957
New +$6.28M
AMZN icon
8
Amazon
AMZN
$2.81T
$3.36M 0.98%
+16,155
New +$3.56M
TMUS icon
9
T-Mobile US
TMUS
$196B
$3.01M 0.88%
+14,347
New +$2.95M
HOOD icon
10
Robinhood
HOOD
$85.5B
$2.19M 0.64%
+31,625
New +$2.78M
ONON icon
11
On Holding
ONON
$9.99B
$1.71M 0.5%
+50,150
New +$2.19M
BSX icon
12
Boston Scientific
BSX
$71.5B
$1.67M 0.49%
+26,667
New +$2.13M
SPOT icon
13
Spotify
SPOT
$110B
$1.32M 0.38%
+2,715
New +$1.36M
NAMS icon
14
NewAmsterdam Pharma
NAMS
$3.41B
$823K 0.24%
+25,721
New +$838K
CGON icon
15
CG Oncology
CGON
$7.15B
$561K 0.16%
+8,289
New +$470K
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
$502K 0.15%
+183,047
New +$579K
MLYS icon
17
Mineralys Therapeutics
MLYS
$2.38B
$463K 0.13%
+17,081
New +$501K
FENC icon
18
Fennec Pharmaceuticals
FENC
$416M
$327K 0.1%
+53,234
New +$411K
IRON icon
19
Disc Medicine
IRON
$3.08B
$327K 0.1%
+5,115
New +$355K
VRDN icon
20
Viridian Therapeutics
VRDN
$2.78B
$139K 0.04%
+7,126
New +$212K
FCX icon
21
Freeport-McMoran
FCX
$99.7B
$133K 0.04%
+2,258
New +$136K
ACHR icon
22
Archer Aviation
ACHR
$4.69B
$111K 0.03%
+21,534
New +$154K
EWTX icon
23
Edgewise Therapeutics
EWTX
$5.04B
$55K 0.02%
+17,460
New +$503K
AQST icon
24
Aquestive Therapeutics
AQST
$576M
$11.3K ﹤0.01%
+2,720
New +$11K

Similar funds

Eleva Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Eleva Capital held 24 positions worth $343M. Its ten largest holdings account for 98% of the portfolio.

Eleva Capital deployed $382M of net new capital in Q1 2026, opening 24 new positions. Its largest new stake was CRH: 2,654,974 shares worth $279M.

By sector, the portfolio is most concentrated in Materials at 81% of assets, followed by Technology and Communication Services.

  • Eleva Capital's largest Q1 2026 buy was CRH: 2,654,974 shares worth $279M.
  • Eleva Capital's ten largest holdings make up 98% of its $343M portfolio in Q1 2026.
  • Eleva Capital opened 24 new positions and closed 0 in Q1 2026.

Based on Eleva Capital's 13F filing for Q1 2026, filed 15 Apr 2026.